Evolution of COVID-19 patients treated with ImmunoFormulation, a combination of nutraceuticals to reduce symptomatology and improve prognosis: a multi-centred, retrospective cohort study

Mariana Diaz Hernández, Jully Urrea, Luciano Bascoy
doi: https://doi.org/10.1101/2020.12.11.20246561

Article usage

Article usage: December 2020 to January 2025

AbstractFullPdf
Dec 202075739940
Jan 202128828229
Feb 20211401887
Mar 202113737108
Apr 202137911128
May 2021113141119
Jun 202127021275
Jul 20218238392
Aug 202112553120
Sep 20211533067
Oct 2021124572
Nov 2021823555
Dec 2021923459
Jan 2022878281
Feb 2022952940
Mar 202268327
Apr 2022342618
May 2022342223
Jun 202222622
Jul 202228146
Aug 20222698
Sep 2022491515
Oct 202232911
Nov 202220720
Dec 202219717
Jan 202321810
Feb 202315312
Mar 202317812
Apr 20231963
May 202313516
Jun 20231485
Jul 2023906
Aug 202318148
Sep 20231574
Oct 20231812
Nov 202321103
Dec 20231234
Jan 2024903
Feb 20241499
Mar 202412104
Apr 202413310
May 2024814
Jun 20241355
Jul 202413315
Aug 20241928
Sep 202414710
Oct 202421911
Nov 202418110
Dec 20241539
Jan 202516106
Back to top
Posted December 15, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Evolution of COVID-19 patients treated with ImmunoFormulation, a combination of nutraceuticals to reduce symptomatology and improve prognosis: a multi-centred, retrospective cohort study
Mariana Diaz Hernández, Jully Urrea, Luciano Bascoy
medRxiv 2020.12.11.20246561; doi: https://doi.org/10.1101/2020.12.11.20246561
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area